Deferred Tax Assets, Valuation Allowance of Guardant Health, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Guardant Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Guardant Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $788,795,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Guardant Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $788,795,000 +$92,322,000 +13% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q4 2024 $696,473,000 +$92,726,000 +15% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q4 2023 $603,747,000 +$114,707,000 +23% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q4 2022 $489,040,000 +$175,915,000 +56% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $313,125,000 +$188,692,000 +152% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 $124,433,000 -$812,000 -0.65% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $125,245,000 +$59,049,000 +89% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $66,196,000 +$22,516,000 +52% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $43,680,000 31 Dec 2017 10-K 19 Mar 2019 2018 Q4
* An asterisk sign (*) next to the value indicates that the value is likely invalid.